Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Of mice and men: correlations between microRNA-17∼92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia.

Robbins ME, Dakhlallah D, Marsh CB, Rogers LK, Tipple TE.

Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L981-L984. doi: 10.1152/ajplung.00390.2016. Epub 2016 Sep 30.

2.

Behavioral abnormalities in mice lacking mesenchyme-specific Pten.

Borniger JC, Cissé YM, Cantemir-Stone CZ, Bolon B, Nelson RJ, Marsh CB.

Behav Brain Res. 2016 May 1;304:80-5. doi: 10.1016/j.bbr.2016.02.016. Epub 2016 Feb 11.

PMID:
26876012
3.

Center of excellence for mobile sensor data-to-knowledge (MD2K).

Kumar S, Abowd GD, Abraham WT, al'Absi M, Beck JG, Chau DH, Condie T, Conroy DE, Ertin E, Estrin D, Ganesan D, Lam C, Marlin B, Marsh CB, Murphy SA, Nahum-Shani I, Patrick K, Rehg JM, Sharmin M, Shetty V, Sim I, Spring B, Srivastava M, Wetter DW.

J Am Med Inform Assoc. 2015 Nov;22(6):1137-42. doi: 10.1093/jamia/ocv056. Epub 2015 Jul 3.

4.

Attenuation of miR-17∼92 Cluster in Bronchopulmonary Dysplasia.

Rogers LK, Robbins M, Dakhlallah D, Yang Z, Lee LJ, Mikhail M, Nuovo G, Pryhuber GS, McGwin G, Marsh CB, Tipple TE.

Ann Am Thorac Soc. 2015 Oct;12(10):1506-13. doi: 10.1513/AnnalsATS.201501-058OC.

5.

The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.

Schilter H, Cantemir-Stone CZ, Leksa V, Ohradanova-Repic A, Findlay AD, Deodhar M, Stockinger H, Song X, Molloy M, Marsh CB, Jarolimek W.

Immunol Lett. 2015 Jun;165(2):90-101. doi: 10.1016/j.imlet.2015.04.003. Epub 2015 Apr 27.

6.

Supernatants from stored red blood cell (RBC) units, but not RBC-derived microvesicles, suppress monocyte function in vitro.

Muszynski JA, Bale J, Nateri J, Nicol K, Wang Y, Wright V, Marsh CB, Gavrilin MA, Sarkar A, Wewers MD, Hall MW.

Transfusion. 2015 Aug;55(8):1937-45. doi: 10.1111/trf.13084. Epub 2015 Mar 27.

PMID:
25819532
7.

MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.

Dakhlallah D, Zhang J, Yu L, Marsh CB, Angelos MG, Khan M.

J Cardiovasc Pharmacol. 2015 Mar;65(3):241-51. doi: 10.1097/FJC.0000000000000183.

8.

Involvement of tumor macrophage HIFs in chemotherapy effectiveness: mathematical modeling of oxygen, pH, and glutathione.

Chen D, Bobko AA, Gross AC, Evans R, Marsh CB, Khramtsov VV, Eubank TD, Friedman A.

PLoS One. 2014 Oct 8;9(10):e107511. doi: 10.1371/journal.pone.0107511. eCollection 2014.

9.

MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.

Kabbout M, Dakhlallah D, Sharma S, Bronisz A, Srinivasan R, Piper M, Marsh CB, Ostrowski MC.

PLoS One. 2014 Jun 26;9(6):e100693. doi: 10.1371/journal.pone.0100693. eCollection 2014.

10.

Macrophage colony-stimulating factor augments Tie2-expressing monocyte differentiation, angiogenic function, and recruitment in a mouse model of breast cancer.

Forget MA, Voorhees JL, Cole SL, Dakhlallah D, Patterson IL, Gross AC, Moldovan L, Mo X, Evans R, Marsh CB, Eubank TD.

PLoS One. 2014 Jun 3;9(6):e98623. doi: 10.1371/journal.pone.0098623. eCollection 2014.

11.

Airborne agricultural particulate matter induces inflammatory cytokine secretion by respiratory epithelial cells: mechanisms of regulation by eicosanoid lipid signal mediators.

Malireddy S, Lawson C, Steinhour E, Hart J, Kotha SR, Patel RB, Zhao L, Wilkins JR, Marsh CB, Magalang UJ, Romberger D, Wewers MD, Parinandi NL.

Indian J Biochem Biophys. 2013 Oct;50(5):387-401.

PMID:
24772960
12.

Methodological challenges in utilizing miRNAs as circulating biomarkers.

Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M.

J Cell Mol Med. 2014 Mar;18(3):371-90. doi: 10.1111/jcmm.12236. Epub 2014 Feb 18. Review.

13.

Chronic restraint stress upregulates erythropoiesis through glucocorticoid stimulation.

Voorhees JL, Powell ND, Moldovan L, Mo X, Eubank TD, Marsh CB.

PLoS One. 2013 Oct 18;8(10):e77935. doi: 10.1371/journal.pone.0077935. eCollection 2013.

14.

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE Jr, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP.

Am J Respir Crit Care Med. 2014 Jan 15;189(2):214-22. doi: 10.1164/rccm.201306-1141WS.

15.

Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.

Voorhees JL, Tarr AJ, Wohleb ES, Godbout JP, Mo X, Sheridan JF, Eubank TD, Marsh CB.

PLoS One. 2013;8(3):e58488. doi: 10.1371/journal.pone.0058488. Epub 2013 Mar 8.

16.

Towards a "4I" approach to personalized healthcare.

Payne PR, Marsh CB.

Clin Transl Med. 2012 Jul 30;1(1):14. doi: 10.1186/2001-1326-1-14.

17.

Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.

Dakhlallah D, Batte K, Wang Y, Cantemir-Stone CZ, Yan P, Nuovo G, Mikhail A, Hitchcock CL, Wright VP, Nana-Sinkam SP, Piper MG, Marsh CB.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):397-405. doi: 10.1164/rccm.201205-0888OC. Epub 2013 Jan 10.

18.

Macrophage microvesicles induce macrophage differentiation and miR-223 transfer.

Ismail N, Wang Y, Dakhlallah D, Moldovan L, Agarwal K, Batte K, Shah P, Wisler J, Eubank TD, Tridandapani S, Paulaitis ME, Piper MG, Marsh CB.

Blood. 2013 Feb 7;121(6):984-95. doi: 10.1182/blood-2011-08-374793. Epub 2012 Nov 9.

19.

Commentary: a ray of hope for medical school research funding.

Gabbe SG, Lockwood CJ, Marsh CB.

Acad Med. 2012 Nov;87(11):1464-5. doi: 10.1097/ACM.0b013e31826b84dd.

PMID:
23111257
20.

Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.

Chen D, Roda JM, Marsh CB, Eubank TD, Friedman A.

Bull Math Biol. 2012 Nov;74(11):2752-77. doi: 10.1007/s11538-012-9776-3. Epub 2012 Oct 17.

21.

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model.

Roda JM, Wang Y, Sumner LA, Phillips GS, Marsh CB, Eubank TD.

J Immunol. 2012 Sep 15;189(6):3168-77. doi: 10.4049/jimmunol.1103817. Epub 2012 Aug 6.

22.

Challenges and opportunities in implementing pharmacogenomics testing in the clinics.

Wisler JR, Wisler JW, Bansal S, Marsh CB.

Per Med. 2012 Aug;9(6):609-619. doi: 10.2217/pme.12.64.

PMID:
29768798
23.

Identifying common genes and networks in multi-organ fibrosis.

Wenzke KE, Cantemir-Stone C, Zhang J, Marsh CB, Huang K.

AMIA Jt Summits Transl Sci Proc. 2012;2012:106-15. Epub 2012 Mar 19.

24.

Modeling the inhibition of breast cancer growth by GM-CSF.

Szomolay B, Eubank TD, Roberts RD, Marsh CB, Friedman A.

J Theor Biol. 2012 Jun 21;303:141-51. doi: 10.1016/j.jtbi.2012.03.024. Epub 2012 Mar 28.

PMID:
22763136
25.

Mesenchymal stem cells for cardiac regeneration: translation to bedside reality.

Elnakish MT, Hassan F, Dakhlallah D, Marsh CB, Alhaider IA, Khan M.

Stem Cells Int. 2012;2012:646038. doi: 10.1155/2012/646038. Epub 2012 Jun 7.

26.

Program in pharmacogenomics at the Ohio State University Medical Center.

Kitzmiller JP, Embi PJ, Manickam K, Sweet KM, Phelps MA, Jackson RD, Marsh CB, Sadee W.

Pharmacogenomics. 2012 May;13(7):751-6. doi: 10.2217/pgs.12.46. No abstract available.

27.

The association between body mass index, processes of care, and outcomes from mechanical ventilation: a prospective cohort study.

O'Brien JM Jr, Philips GS, Ali NA, Aberegg SK, Marsh CB, Lemeshow S.

Crit Care Med. 2012 May;40(5):1456-63. doi: 10.1097/CCM.0b013e31823e9a80.

PMID:
22430246
28.

Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide.

Patel RB, Kotha SR, Sauers LA, Malireddy S, Gurney TO, Gupta NN, Elton TS, Magalang UJ, Marsh CB, Haley BE, Parinandi NL.

Toxicol Mech Methods. 2012 Jun;22(5):383-96. doi: 10.3109/15376516.2012.673089.

29.

A database de-identification framework to enable direct queries on medical data for secondary use.

Erdal BS, Liu J, Ding J, Chen J, Marsh CB, Kamal J, Clymer BD.

Methods Inf Med. 2012;51(3):229-41. doi: 10.3414/ME11-01-0048. Epub 2012 Feb 7.

PMID:
22311158
30.

M-CSF induces monocyte survival by activating NF-κB p65 phosphorylation at Ser276 via protein kinase C.

Wang Y, Mo X, Piper MG, Wang H, Parinandi NL, Guttridge D, Marsh CB.

PLoS One. 2011;6(12):e28081. doi: 10.1371/journal.pone.0028081. Epub 2011 Dec 22.

31.

Phospholipase A(2) activation by poultry particulate matter is mediated through extracellular signal-regulated kinase in lung epithelial cells: regulation of interleukin-8 release.

Kotha SR, Piper MG, Patel RB, Sliman S, Malireddy S, Zhao L, Baran CP, Nana-Sinkam PS, Wewers MD, Romberger D, Marsh CB, Parinandi NL.

Cell Biochem Biophys. 2013 Nov;67(2):415-29. doi: 10.1007/s12013-011-9329-7.

PMID:
22183614
32.

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.

Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F, Yu L, Fernandez SA, Pécot T, Rosol TJ, Cory S, Hallett M, Park M, Piper MG, Marsh CB, Yee LD, Jimenez RE, Nuovo G, Lawler SE, Chiocca EA, Leone G, Ostrowski MC.

Nat Cell Biol. 2011 Dec 18;14(2):159-67. doi: 10.1038/ncb2396.

33.

In vivo monitoring of pH, redox status, and glutathione using L-band EPR for assessment of therapeutic effectiveness in solid tumors.

Bobko AA, Eubank TD, Voorhees JL, Efimova OV, Kirilyuk IA, Petryakov S, Trofimiov DG, Marsh CB, Zweier JL, Grigor'ev IA, Samouilov A, Khramtsov VV.

Magn Reson Med. 2012 Jun;67(6):1827-36. doi: 10.1002/mrm.23196. Epub 2011 Nov 23.

34.

The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis.

Nuovo GJ, Hagood JS, Magro CM, Chin N, Kapil R, Davis L, Marsh CB, Folcik VA.

Mod Pathol. 2012 Mar;25(3):416-33. doi: 10.1038/modpathol.2011.166. Epub 2011 Oct 28.

35.

HIFs: a-cute answer to inflammation?

Eubank TD, Marsh CB.

Blood. 2011 Jul 21;118(3):485-7. doi: 10.1182/blood-2011-05-355164. No abstract available.

36.

Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.

Roda JM, Sumner LA, Evans R, Phillips GS, Marsh CB, Eubank TD.

J Immunol. 2011 Aug 15;187(4):1970-6. doi: 10.4049/jimmunol.1100841. Epub 2011 Jul 15.

37.

Asc-dependent and independent mechanisms contribute to restriction of legionella pneumophila infection in murine macrophages.

Abdelaziz DH, Gavrilin MA, Akhter A, Caution K, Kotrange S, Khweek AA, Abdulrahman BA, Hassan ZA, El-Sharkawi FZ, Bedi SS, Ladner K, Gonzalez-Mejia ME, Doseff AI, Mostafa M, Kanneganti TD, Guttridge D, Marsh CB, Wewers MD, Amer AO.

Front Microbiol. 2011 Feb 14;2:18. doi: 10.3389/fmicb.2011.00018. eCollection 2011.

38.

An in silico modeling approach to understanding the dynamics of sarcoidosis.

Aguda BD, Marsh CB, Thacker M, Crouser ED.

PLoS One. 2011;6(5):e19544. doi: 10.1371/journal.pone.0019544. Epub 2011 May 27.

39.

Thrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity.

McMaken S, Exline MC, Mehta P, Piper M, Wang Y, Fischer SN, Newland CA, Schrader CA, Balser SR, Sarkar A, Baran CP, Marsh CB, Cook CH, Phillips GS, Ali NA.

PLoS One. 2011 May 9;6(5):e19654. doi: 10.1371/journal.pone.0019654.

40.

Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.

Baran CP, Fischer SN, Nuovo GJ, Kabbout MN, Hitchcock CL, Bringardner BD, McMaken S, Newland CA, Cantemir-Stone CZ, Phillips GS, Ostrowski MC, Marsh CB.

Am J Respir Cell Mol Biol. 2011 Nov;45(5):999-1006. doi: 10.1165/rcmb.2010-0490OC. Epub 2011 May 11.

41.

Using an agent-based model to analyze the dynamic communication network of the immune response.

Folcik VA, Broderick G, Mohan S, Block B, Ekbote C, Doolittle J, Khoury M, Davis L, Marsh CB.

Theor Biol Med Model. 2011 Jan 19;8:1. doi: 10.1186/1742-4682-8-1.

42.

Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.

Patel RB, Kotha SR, Sherwani SI, Sliman SM, Gurney TO, Loar B, Butler SO, Morris AJ, Marsh CB, Parinandi NL.

Int J Toxicol. 2011 Feb;30(1):69-90. doi: 10.1177/1091581810388850. Epub 2010 Dec 3.

43.

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes.

Eubank TD, Roda JM, Liu H, O'Neil T, Marsh CB.

Blood. 2011 Jan 6;117(1):323-32. doi: 10.1182/blood-2010-01-261792. Epub 2010 Oct 15.

44.

Organ-derived coatings on electrospun nanofibers as ex vivo microenvironments.

Fischer SN, Johnson JK, Baran CP, Newland CA, Marsh CB, Lannutti JJ.

Biomaterials. 2011 Jan;32(2):538-46. doi: 10.1016/j.biomaterials.2010.08.104. Epub 2010 Sep 26.

45.

Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis.

Ezzie ME, Piper MG, Montague C, Newland CA, Opalek JM, Baran C, Ali N, Brigstock D, Lawler J, Marsh CB.

Am J Respir Cell Mol Biol. 2011 Apr;44(4):556-61. doi: 10.1165/rcmb.2009-0019OC. Epub 2010 Jun 25.

46.

sRAGE induces human monocyte survival and differentiation.

Wang Y, Wang H, Piper MG, McMaken S, Mo X, Opalek J, Schmidt AM, Marsh CB.

J Immunol. 2010 Aug 1;185(3):1822-35. doi: 10.4049/jimmunol.0903398. Epub 2010 Jun 23.

47.

The role of heat shock protein 27 in bronchiolitis obliterans syndrome after lung transplantation.

Wood KL, Nunley DR, Moffatt-Bruce S, Pope-Harman A, Huang Q, Shamo EN, Phillips GS, Baran C, Batra S, Marsh CB, Doseff AI.

J Heart Lung Transplant. 2010 Jul;29(7):786-91. doi: 10.1016/j.healun.2010.03.004. Epub 2010 Apr 24.

48.

Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.

Butchar JP, Mehta P, Justiniano SE, Guenterberg KD, Kondadasula SV, Mo X, Chemudupati M, Kanneganti TD, Amer A, Muthusamy N, Jarjoura D, Marsh CB, Carson WE 3rd, Byrd JC, Tridandapani S.

Clin Cancer Res. 2010 Apr 1;16(7):2065-75. doi: 10.1158/1078-0432.CCR-09-2591. Epub 2010 Mar 23.

49.

Personalized healthcare in clotting disorders.

Wu HM, Xu L, Sedmak DD, Marsh CB, Wurster MW.

Per Med. 2010 Jan;7(1):65-73.

50.

MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response.

Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, Elton TS, Gunn JS, Amer A, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S.

PLoS One. 2009 Dec 30;4(12):e8508. doi: 10.1371/journal.pone.0008508.

Supplemental Content

Loading ...
Support Center